Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 315858, 8 pages
http://dx.doi.org/10.1155/2011/315858
Research Article

Cattle Bile Aggravates Diclofenac Sodium-Induced Small Intestinal Injury in Mice

Division of Clinical Application, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan

Received 17 November 2010; Revised 17 February 2011; Accepted 18 February 2011

Copyright © 2011 Hironori Ishikawa and Shiro Watanabe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Trevethick, I. Oakley, N. M. Clayton, and P. Strong, “Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: underlying pathological mechanisms,” General Pharmacology, vol. 26, no. 7, pp. 1455–1459, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Adebayo and I. Bjarnason, “Is nonsteroidal anti-inflammatory drugs (NSAIDs) enteropathy clinically more important than NSAID gastropathy?” Postgraduate Medical Journal, vol. 82, pp. 186–191, 2006. View at Google Scholar
  3. I. Bjarnason, P. Prouse, and T. Smith, “Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs,” The Lancet, vol. 2, no. 8561, pp. 711–714, 1987. View at Google Scholar
  4. N. M. Davies, F. Jamali, and K. J. Skeith, “Nonsteroidal antiinflammatory drug-induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 39, no. 2, pp. 321–324, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Maiden, B. Thjodleifsson, A. Theodors, J. Gonzalez, and I. Bjarnason, “A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy,” Gastroenterology, vol. 128, no. 5, pp. 1172–1178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Evans, F. László, and B. J. R. Whittle, “Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine,” European Journal of Pharmacology, vol. 388, no. 3, pp. 281–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Weissenborn, S. Maedge, D. Buettner, and K. F. Sewing, “Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion of the rat,” Pharmacology, vol. 30, no. 1, pp. 32–39, 1985. View at Google Scholar · View at Scopus
  8. K. Takeuchi, A. Tanaka, S. Kato, K. Amagase, and H. Satoh, “Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage,” Clinica Chimica Acta, vol. 411, no. 7-8, pp. 459–466, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. L. M. Velardi, A. K. Groen, R. P. J. Oude Elferink, R. van der Meer, G. Palasciano, and G. N. J. Tytgat, “Cell type-dependent effect of phospholipid and cholesterol on bile salt cytotoxicity,” Gastroenterology, vol. 101, no. 2, pp. 457–464, 1991. View at Google Scholar · View at Scopus
  10. M. Petruzzelli, A. Moschetta, W. Renooij et al., “Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury,” Digestive Diseases and Sciences, vol. 51, no. 4, pp. 766–774, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. M. Lichtenberger, Z. M. Wang, J. J. Romero et al., “Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury,” Nature Medicine, vol. 1, no. 2, pp. 154–158, 1995. View at Google Scholar · View at Scopus
  12. M. Petruzzelli, M. Vacca, A. Moschetta et al., “Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts,” Clinical Biochemistry, vol. 40, no. 8, pp. 503–510, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. Uchida, T. Yamada, T. Hayakawa, and M. Hoshino, “Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation,” American Journal of Physiology, vol. 272, no. 5, pp. G1249–G1257, 1997. View at Google Scholar · View at Scopus
  14. J. D. Lloyd-Still, D. W. A. Beno, M. R. Uhing, V. A. Jiyamapa-Serna, and R. E. Kimura, “Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat,” Journal of Pediatric Gastroenterology and Nutrition, vol. 32, no. 3, pp. 270–273, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Watanabe, T. Kamei, K. Tanaka, K. Kawasuji, T. Yoshioka, and M. Ohno, “Roles of bile acid conjugates and phospholipids in in vitro activation of pancreatic lipase by bear bile and cattle bile,” Journal of Ethnopharmacology, vol. 125, no. 2, pp. 203–206, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. A. Woollett, D. D. Buckley, L. Yao et al., “Cholic acid supplementation enhances cholesterol absorption in humans,” Gastroenterology, vol. 126, no. 3, pp. 724–731, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, P. J. H. Jones, L. A. Woollett et al., “Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans,” Translational Research, vol. 148, no. 1, pp. 37–45, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. C. Torchia, E. D. Labonté, and L. B. Agellon, “Separation and quantitation of bile acids using an isocratic solvent system for high performance liquid chromatography coupled to an evaporative light scattering detector,” Analytical Biochemistry, vol. 298, no. 2, pp. 293–298, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. K. Dobashi, E. Ohkoshi, Y. Fujii, M. Nagai, and S. Watanabe, “Scutellariae Radix aggravates diclofenac sodium-induced enteropathy in mice,” Journal of Traditional Medicines, vol. 25, no. 3, pp. 81–86, 2008. View at Google Scholar
  20. E. Persson, L. Löfgren, G. Hansson, B. Abrahamsson, H. Lennernäs, and R. Nilsson, “Simultaneous assessment of lipid classes and bile acids in human intestinal fluid by solid-phase extraction and HPLC methods,” Journal of Lipid Research, vol. 48, no. 1, pp. 242–251, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Naoi, S. Kogure, M. Saito, T. Hamazaki, and S. Watanabe, “Differential effects of selective cyclooxygenase (COX)-1 and COX-2 inhibitors on anorexic response and prostaglandin generation in various tissues induced by zymosan,” Biological and Pharmaceutical Bulletin, vol. 29, no. 7, pp. 1319–1324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Y. Ma, D. Hollander, D. Bhalla, H. Nguyen, and P. Krugliak, “IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability,” Journal of Laboratory and Clinical Medicine, vol. 120, no. 2, pp. 329–341, 1992. View at Google Scholar · View at Scopus
  23. D. M. Heuman, “Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions,” Journal of Lipid Research, vol. 30, no. 5, pp. 719–730, 1989. View at Google Scholar · View at Scopus
  24. Y. Araki, T. Tsujikawa, A. Andoh, M. Sasaki, Y. Fujiyama, and T. Bamba, “Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen,” Digestive and Liver Disease, vol. 32, no. 8, pp. 691–698, 2000. View at Google Scholar · View at Scopus
  25. E. J. Dial, R. L. Darling, and L. M. Lichtenberger, “Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury,” Journal of Gastroenterology and Hepatology, vol. 23, no. 8, pp. e384–e389, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. Jacob, R. Foster, G. Sigthorsson, R. Simpson, and I. Bjarnason, “Role of bile in pathogenesis of indomethacin-induced enteropathy,” Archives of Toxicology, vol. 81, no. 4, pp. 291–298, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. G. Alpini, Y. Ueno, S. S. Glaser et al., “Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes,” Hepatology, vol. 34, no. 5, pp. 868–876, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. R. H. Huntjens, A. Strougo, A. Chain et al., “Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats,” British Journal of Pharmacology, vol. 153, no. 5, pp. 1072–1084, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. S. Seitz and U. A. Boelsterli, “Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats,” Gastroenterology, vol. 115, no. 6, pp. 1476–1482, 1998. View at Google Scholar · View at Scopus